Stau2 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Stau2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The STAU2 (Staufen2) gene encodes a member of the Staufen family of RNA-binding proteins involved in mRNA transport, localization, and translation regulation in neurons. Staufen2 is essential for dendritic mRNA targeting and synaptic plasticity. Located at 8q13.3, STAU2 dysfunction has been implicated in Alzheimer's disease, ALS, and neurodevelopmental disorders.
| Attribute | Value |
|---|---|
| Gene Symbol | STAU2 |
| Full Name | Staufen2 |
| Chromosomal Location | 8q13.3 |
| NCBI Gene ID | 27067 |
| OMIM | 607010 |
| Ensembl ID | ENSG00000100095 |
| UniProt ID | Q9NUR2 |
Staufen2 binds to mRNAs containing dendritic targeting elements (DTEs) and transports them along microtubules from the soma to dendrites. This transport is essential for local protein synthesis at synapses.
By regulating local translation of synaptic proteins, Staufen2 modulates synaptic strength and plasticity. It participates in both long-term potentiation (LTP) and long-term depression (LTD).
Staufen2 is a key component of neuronal RNA granules, including stress granules and processing bodies (P-bodies). These granules regulate mRNA stability, translation, and degradation.
Staufen2 is expressed in neural progenitor cells and regulates genes involved in neuronal differentiation and migration.
STAU2 expression is altered in AD brains, with reduced levels in early AD and compensatory increases in later stages. STAU2 dysregulation may contribute to synaptic dysfunction by impairing local translation of synaptic proteins.
STAU2-containing stress granules accumulate in ALS motor neurons. TDP-43 pathology sequesters STAU2 and other RNA-binding proteins, disrupting mRNA transport and local translation in motor neurons.
STAU2 variants have been identified in patients with autism spectrum disorder and intellectual disability, suggesting a role in neurodevelopment.
Altered STAU2 expression has been reported in epileptic tissue, potentially affecting synaptic function and excitability.
STAU2 is highly expressed in:
Expression is particularly high in dendritic compartments, consistent with its role in dendritic mRNA localization.
| Approach | Status | Notes |
|---|---|---|
| mRNA transport modulators | Research | Enhancing mRNA delivery to dendrites |
| Stress granule inhibitors | Research | Preventing pathological granule accumulation |
| Gene therapy | Preclinical | Restoring STAU2 expression |
| Small molecule synaptic enhancers | Research | Compensation for transport deficits |
Stau2 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Stau2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.